E. Campbell

发表

In vitro characterization of a peripheral afferent pathway of the rat after chronic sciatic nerve section.

L. Urbán, C. Gentry, R. Babbedge, 1996, Journal of neurophysiology.

Analogues of capsaicin with agonist activity as novel analgesic agents: structure-activity studies. 4. Potent, orally active analgesics.

S. Bevan, R. Wrigglesworth, J. Winter, 1996, Journal of medicinal chemistry.

Bradyzide, a potent non‐peptide B2 bradykinin receptor antagonist with long‐lasting oral activity in animal models of inflammatory hyperalgesia

P. McIntyre, R. Wrigglesworth, C. Snell, 2000, British journal of pharmacology.

PII: S0304-3959(00)00288-8

L. Urbán, S. Cruwys, B. Kidd, 2000 .

Antinociceptive activity of the bradykinin B1 and B2 receptor antagonists, des-Arg9, [Leu8]-BK and HOE 140, in two models of persistent hyperalgesia in the rat

A. Dray, E. Campbell, M. Perkins, 1993, Pain.

B1 bradykinin receptors and sensory neurones

L. Urbán, S. Phagoo, G. Burgess, 1996, British journal of pharmacology.

2-Nitrophenylcarbamoyl-(S)-prolyl-(S)-3-(2-naphthyl)alanyl-N-benzyl-N - methylamide (SDZ NKT 343), a potent human NK1 tachykinin receptor antagonist with good oral analgesic activity in chronic pain models.

S. Ko, L. Urbán, M. Lemaire, 1998, Journal of medicinal chemistry.

Selective neurokinin-1 receptor antagonists are anti-hyperalgesic in a model of neuropathic pain in the guinea-pig

L. Urbán, C. Gentry, S. Patel, 1998, Neuroscience.

Analogues of capsaicin with agonist activity as novel analgesic agents; structure-activity studies. 2. The amide bond "B-region".

S. Bevan, R. Wrigglesworth, J. Winter, 1993, Journal of medicinal chemistry.

Analogues of capsaicin with agonist activity as novel analgesic agents; structure-activity studies. 3. The hydrophobic side-chain "C-region".

S. Bevan, R. Wrigglesworth, J. Winter, 1993, Journal of medicinal chemistry.

Oral anti-hyperalgesic and anti-inflammatory activity of NK1 receptor antagonists in models of inflammatory hyperalgesia of the guinea-pig

L. Urbán, S. Cruwys, B. Kidd, 2000, Pain.

Comparative, general pharmacology of SDZ NKT 343, a novel, selective NK1 receptor antagonist

P. McIntyre, K. Buchheit, L. Urbán, 1998, British journal of pharmacology.

Analogues of capsaicin with agonist activity as novel analgesic agents; structure-activity studies. 1. The aromatic "A-region".

S. Bevan, R. Wrigglesworth, A. Dray, 1993, Journal of medicinal chemistry.

Biphenyl-derivatives of 2-amino-7-phosphono-heptanoic acid, a novel class of potent competitive N-Methyl-D-aspartate receptor antagonists—II. Pharmacological characterization in vivo

S. Urwyler, P. Jenner, G. Fricker, 1996, Neuropharmacology.

Capsaicin and pain mechanisms.

S. Bevan, J. Winter, E. Campbell, 1995, British journal of anaesthesia.

Capsazepine reversal of the antinociceptive action of capsaicin in vivo

E. Campbell, M. Perkins, 1992, British journal of pharmacology.

Clinical and experimental studies in the role of GABA in the regulation of ACTH secretion

V. Wynn, M. Jones, A. Thody, 1984, Neuropharmacology.

In vivo pharmacology of SDZ 249-665, a novel, non-pungent capsaicin analogue

K. Buchheit, L. Urbán, M. Panesar, 2000, Pain.

Biphenyl-derivatives of 2-amino-7-phosphono-heptanoic acid, a novel class of potent competitive N-methyl-D-aspartate receptor antagonists--II. Pharmacological characterization in vivo.

M. Rudin, A. Sauter, S. Urwyler, 1996, Neuropharmacology.